News | February 03, 2008

Nucletron Reports First IMRT Treatment Within CHHiP Clinical Trial With Oncentra MasterPlan

February 4, 2008 - Nucletron BV and clinicians at The Cancer Centre, Northern Ireland, proudly report the first IMRT clinical treatment within the Conventional or Hypofractionated High-Dose Intensity Modulated Radiotherapy for Prostate Cancer (CHHiP) clinical trial utilizing Nucletron's Oncentra MasterPlan.

CHHiP, part of the NCRN/NCRI portfolio of cancer trials and sponsored by the Institute of Cancer Research, is a Phase III national, multi-centre, randomized trial for the treatment of prostate cancer using external beam radiotherapy.

The IMRT module, Oncentra Optimizer and its Direct Step & Shoot (DSS) capabilities, provides the right planning tools to shape the radiation doses in a complex multi-target area in the prostate while at the same time reducing the dose in the surrounding healthy tissues, including the bladder and rectum.

“We are very pleased to have started IMRT treatments within this important trial," said Vivian Cosgrove, M.D., clinical scientist at The Cancer Centre, Northern Ireland. “During the clinical work-up, we were impressed by the improvements to the IMRT planning process the Direct Step & Shoot facility can provide, both in terms of planning efficiency and in the conformance of dose to very challenging dose-volume constraints.”

At the Northern Ireland Cancer Centre, Oncentra MasterPlan operates with modern accelerators and CT, MR and PET/CT scanners. Key features of MasterPlan, such as image registration, image fusion and multi-modality imaging, play an important role in uniting information between the imaging and treatment equipment. Features such as mutual information image fusion, extra-planar image reconstruction and manipulation, and fusion verification software capabilities can reduce the time physicians need for contouring target and organs-at-risk volumes. Inherent in MasterPlan is a sophisticated, DICOM RT compliant archive that will make the treatment-planning workflow more efficient and improve plan-data traceability and transfer, within the Cancer Centre and beyond.

For more information: http://www.nucletron.com

Related Content

MR-HIFU, ThermoDox, combination therapy, recurrent childhood tumors, Celsion, Children's National Health System, Phase I clinical study
News | Oncology Related Products | December 19, 2016
December 19, 2016 — Children’s National Health System and Celsion Corp.
News | Clinical Decision Support | October 27, 2016
October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use
contrast-enhanced ultrasound, CEUS, liver cancer, hepatocellular carcinoma, study, Advances in Contrast Ultrasound conference, ICUS
News | Ultrasound Imaging | September 12, 2016
September 12, 2016 — Tiny microbubbles are being used to more effectively...
cardio-oncology, echo strain assessment, echoinsight, epsilon

Epsilon's EchoInsight software helps analyze cardiac function by evaluating wall motion strain. 

Feature | Cardio-oncology | May 13, 2016 | Dave Fornell
Cardio-oncology is an emerging field that combines the expertise of both cardiology and oncology to assess and treat
Carestream, Clinical Collaboration Platform, Fox Valley Hematology & Oncology
News | Enterprise Imaging | April 20, 2016
Fox Valley Hematology & Oncology (Appleton, Wis.) implemented Carestream’s Vue for Clinical Collaboration Platform...
cancer immunotherapy, development, Axel Hoos, Nature Reviews, imaging
News | Oncology Related Products | March 31, 2016
In a paper published in Nature Reviews last week, Axel Hoos, M.D., Ph.D., laid out the current immunotherapy...
Pyrexar, buy back outside ownership, Person Medical, BSD-2000 Hyperthermia System

BSD-2000 image courtesy of Pyrexar Medical

News | Oncology Related Products | March 15, 2016
Pyrexar announced it has purchased back outside ownership from Person Medical (formerly BSD Medical), concluding a...
BTG, LC Bead LUMI, radiopaque embolic bead, Philips Healthcare, Live Image Guidance, liver cancer
News | Interventional Radiology | February 09, 2016
BTG plc and Royal Philips announced a significant milestone in their collaboration with the treatment of the first...
Overlay Init